A new vaccine and treatment for Hepatitis B
Novel Hepatitis B Vaccine and Immunotherapy
This study is testing a new mRNA vaccine and treatment to help people with Hepatitis B by boosting their immune system to fight the virus better, with the hope of finding a cure for the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11136655 on NIH RePORTER |
What this research studies
This research focuses on developing a novel mRNA vaccine and immunotherapy to combat Hepatitis B virus (HBV), which affects over 250 million people globally. The approach aims to not only suppress the virus but also to enhance the body's immune response against it. Researchers will investigate the factors that hinder effective vaccine antigen expression and work on improving these antigens to elicit strong antibody and T cell responses. If successful, this could lead to a cure for HBV and pave the way for similar vaccines against other pathogens.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic Hepatitis B infection.
Not a fit: Patients who have already been cured of Hepatitis B or those without the infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a potential cure for Hepatitis B, significantly improving the health outcomes for millions of infected individuals.
How similar studies have performed: Other research has shown promise with mRNA vaccine technology in combating various viral infections, indicating a potential for success in this novel approach.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Law, Mansun — Scripps Research Institute, the
- Study coordinator: Law, Mansun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.